Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap

Maria A. Rocca; Paolo Preziosa; Massimo Filippi

doi:10.1016/j.medj.2025.100751

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

Therapeutic Plasma Exchange Combined With Immunomodulating Agents in Secondary Progressive Multiple Sclerosis Patients

Eirini Grapsa, Nicolaos Triantafyllou, A. Rombos, A. Lagouranis, Meletios A Dimopoulos

Article2004

T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis

Alessandro Castriota-Scanderbeg, Fabrizio Fasano, Massimo Filippi, Carlo Caltagirone

Article1999

Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis.

Maria A. Rocca, G. Mastronardo, Mariemma Rodegher, Giancarlo Comi, Massimo Filippi

Article1993

BENIGN MULTIPLE-SCLEROSIS AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS - STUDY USING QUANTITATIVE MAGNETIC-RESONANCE

Massimo Filippi, Gareth J. Barker, Mark A. Horsfield, Alan J. Thompson, Iw Mcdonald, DH Miller

Article2005

Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis

Celia Oreja‐Guevara, Marco Rovaris, Giuseppe Iannucci, Paola Valsasina, Domenico Caputo, Rosella Cavarretta, Maria Pia Sormani, Pasquale Ferrante, Giancarlo Comi, Massimo Filippi